Specialized keratin KeraNetics is a global leader in purified, human-derived keratin with a focus on wound healing products such as KeraStat Cream, presenting a clear entry point for dermal and oncology support channels dealing with radiation dermatitis.

Clinical traction FDA-cleared topical product targeting radiation dermatitis suggests established regulatory credibility and a ready-to-market asset that can be expanded to related moist or dry wound care markets with iterative formulations or line extensions.

Mid-market focus Company size (11-50 employees) places KeraNetics in a nimble, specialty segment ideal for targeted direct sales, clinical partnerships, and pilot programs with hospitals, cancer centers, and dermatology clinics.

Growth funding Current revenue range and prior funding indicate venture-aligned growth potential; opportunities exist for partnerships, co-development, or grant-backed programs to scale manufacturing, distribution, and new indications.

Tech-enabled reach Digital marketing stack including LinkedIn Ads and e-commerce components signals readiness for account-based campaigns, channel partnerships, and clinician outreach to drive adoption and expand geographic reach.